178 related articles for article (PubMed ID: 10715361)
1. Serotonergic blunting to meta-chlorophenylpiperazine (m-CPP) highly correlates with sustained childhood abuse in impulsive and autoaggressive female borderline patients.
Rinne T; Westenberg HG; den Boer JA; van den Brink W
Biol Psychiatry; 2000 Mar; 47(6):548-56. PubMed ID: 10715361
[TBL] [Abstract][Full Text] [Related]
2. Association of serotonin and cortisol indices with childhood abuse in bulimia nervosa.
Steiger H; Gauvin L; Israël M; Koerner N; Ng Ying Kin NM; Paris J; Young SN
Arch Gen Psychiatry; 2001 Sep; 58(9):837-43. PubMed ID: 11545666
[TBL] [Abstract][Full Text] [Related]
3. m-Chlorophenylpiperazine challenge in borderline personality disorder: relationship of neuroendocrine response, behavioral response, and clinical measures.
Stein DJ; Hollander E; DeCaria CM; Simeon D; Cohen L; Aronowitz B
Biol Psychiatry; 1996 Sep; 40(6):508-13. PubMed ID: 8879471
[TBL] [Abstract][Full Text] [Related]
4. Blunted hormone responses to Ipsapirone are associated with trait impulsivity in personality disorder patients.
Minzenberg MJ; Grossman R; New AS; Mitropoulou V; Yehuda R; Goodman M; Reynolds DA; Silverman JM; Coccaro EF; Marcus S; Siever LJ
Neuropsychopharmacology; 2006 Jan; 31(1):197-203. PubMed ID: 16123761
[TBL] [Abstract][Full Text] [Related]
5. Self-destructiveness and serotonin function in bulimia nervosa.
Steiger H; Koerner N; Engelberg MJ; Israël M; Ng Ying Kin NM; Young SN
Psychiatry Res; 2001 Aug; 103(1):15-26. PubMed ID: 11472787
[TBL] [Abstract][Full Text] [Related]
6. Childhood sexual abuse in relation to neurobiological challenge tests in patients with borderline personality disorder and normal controls.
Zweig-Frank H; Paris J; Ng Ying Kin NM; Schwartz G; Steiger H; Vasavan Nair NP
Psychiatry Res; 2006 Mar; 141(3):337-41. PubMed ID: 16497388
[TBL] [Abstract][Full Text] [Related]
7. Neurobiological correlates of diagnosis and underlying traits in patients with borderline personality disorder compared with normal controls.
Paris J; Zweig-Frank H; Kin NM; Schwartz G; Steiger H; Nair NP
Psychiatry Res; 2004 Jan; 121(3):239-52. PubMed ID: 14675743
[TBL] [Abstract][Full Text] [Related]
8. Serotonin dysfunction in pathological gamblers: increased prolactin response to oral m-CPP versus placebo.
Pallanti S; Bernardi S; Quercioli L; DeCaria C; Hollander E
CNS Spectr; 2006 Dec; 11(12):956-64. PubMed ID: 17146409
[TBL] [Abstract][Full Text] [Related]
9. 5-HT1A dysfunction in borderline personality disorder.
Hansenne M; Pitchot W; Pinto E; Reggers J; Scantamburlo G; Fuchs S; Pirard S; Ansseau M
Psychol Med; 2002 Jul; 32(5):935-41. PubMed ID: 12171388
[TBL] [Abstract][Full Text] [Related]
10. Serotonin hypothesis of winter depression: behavioral and neuroendocrine effects of the 5-HT(1A) receptor partial agonist ipsapirone in patients with seasonal affective disorder and healthy control subjects.
Schwartz PJ; Turner EH; Garcia-Borreguero D; Sedway J; Vetticad RG; Wehr TA; Murphy DL; Rosenthal NE
Psychiatry Res; 1999 Apr; 86(1):9-28. PubMed ID: 10359479
[TBL] [Abstract][Full Text] [Related]
11. A comparison of posttraumatic stress disorder with and without borderline personality disorder among women with a history of childhood sexual abuse: etiological and clinical characteristics.
Heffernan K; Cloitre M
J Nerv Ment Dis; 2000 Sep; 188(9):589-95. PubMed ID: 11009332
[TBL] [Abstract][Full Text] [Related]
12. [Negative experiences in childhood, stress and self-injurious behavior and suicidal tendencies in people with borderline personality].
Blasczyk-Schiep S; Jaworska-Andryszewska P
Pol Merkur Lekarski; 2014 Jun; 36(216):389-93. PubMed ID: 25095638
[TBL] [Abstract][Full Text] [Related]
13. [Personality disorders and psychopathology following trauma. Reflection on diagnostic classification].
Wöller W; Kruse J
Nervenarzt; 2003 Nov; 74(11):972-6. PubMed ID: 14598033
[TBL] [Abstract][Full Text] [Related]
14. Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users.
McCann UD; Eligulashvili V; Mertl M; Murphy DL; Ricaurte GA
Psychopharmacology (Berl); 1999 Nov; 147(1):56-65. PubMed ID: 10591869
[TBL] [Abstract][Full Text] [Related]
15. Serotonergic responsivity and behavioral dimensions in antisocial personality disorder with substance abuse.
Moss HB; Yao JK; Panzak GL
Biol Psychiatry; 1990 Aug; 28(4):325-38. PubMed ID: 2397249
[TBL] [Abstract][Full Text] [Related]
16. 5HT2A receptor binding is increased in borderline personality disorder.
Soloff PH; Price JC; Meltzer CC; Fabio A; Frank GK; Kaye WH
Biol Psychiatry; 2007 Sep; 62(6):580-7. PubMed ID: 17448449
[TBL] [Abstract][Full Text] [Related]
17. Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse.
Rinne T; de Kloet ER; Wouters L; Goekoop JG; DeRijk RH; van den Brink W
Biol Psychiatry; 2002 Dec; 52(11):1102-12. PubMed ID: 12460693
[TBL] [Abstract][Full Text] [Related]
18. Bipolar affective disorder and borderline personality disorder: Differentiation based on the history of early life stress and psychoneuroendocrine measures.
Mazer AK; Cleare AJ; Young AH; Juruena MF
Behav Brain Res; 2019 Jan; 357-358():48-56. PubMed ID: 29702176
[TBL] [Abstract][Full Text] [Related]
19. Heart rate variability in patients with post-traumatic stress disorder or borderline personality disorder: relationship to early life maltreatment.
Meyer PW; Müller LE; Zastrow A; Schmidinger I; Bohus M; Herpertz SC; Bertsch K
J Neural Transm (Vienna); 2016 Sep; 123(9):1107-18. PubMed ID: 27311838
[TBL] [Abstract][Full Text] [Related]
20. The meta-chlorophenylpiperazine challenge test in cocaine addicts: hormonal and psychological responses.
Buydens-Branchey L; Branchey M; Fergeson P; Hudson J; McKernin C
Biol Psychiatry; 1997 Jun; 41(11):1071-86. PubMed ID: 9146818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
